Keywords: آنتی بادی های درمانی; High-throughput sequencing of immune repertoire (HTS-IR); Tumor biomarker; Therapeutic antibodies; CAR-T cell-based adoptive immunotherapy; TCR-T cell-based adoptive immunotherapy;
مقالات ISI آنتی بادی های درمانی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی بادی های درمانی; Monoclonal antibodies (mAbs); Therapeutic antibodies; Biologicals; Biosimilars; Biobetters; Antibody engineering; Antibody drug conjugates (ADC); Bispecific antibodies; Manufacture; Degradation; Stability; Formulation;
Keywords: آنتی بادی های درمانی; Flavivirus; Dengue virus; Antibody; Neutralization mechanism; Therapeutic antibodies
Keywords: آنتی بادی های درمانی; Antibody; Glycosylation; Structure; Therapeutic antibodies; Effector function; Glycan;
Keywords: آنتی بادی های درمانی; Abs; antibodies; ATG; antithymocyte globulin; BSX; basiliximab; DSA; donor-specific antibody; DTT; dithiothreitol; ECZ; eculizumab; FC; flow cytometry; HLA; human leukocyte antigen; IVIg; intravenous immunoglobulin; LCT; lymphocytotoxicity; MoAbs; monoclo
Keywords: آنتی بادی های درمانی; Polyanhydrides; Nanoparticles; Therapeutic antibodies; Delivery; Stability;
Keywords: آنتی بادی های درمانی; Personalised medicine; Monoclonal antibodies; Therapeutic antibodies; Antibody development; Antibody modifications
Keywords: آنتی بادی های درمانی; Therapeutic antibodies; Mannose receptor; Pharmacokinetics; Antibody structureHM, high mannose type glycan; M5 (or M#), high mannose glycan 5 (or other number); CO, complex type glycan; mAb, monoclonal antibody; ADCC, antibody-dependent cell-mediated cyto
Therapeutic monoclonal antibody N-glycosylation - Structure, function and therapeutic potential
Keywords: آنتی بادی های درمانی; IgG; Glycans; Glycosylation; Fc-receptors; ADCC; ADCP; CDC; Effector function; Therapeutic antibodies;
RGD cadherins and α2β1 integrin in cancer metastasis: A dangerous liaison
Keywords: آنتی بادی های درمانی; Cadherin 17; VE-cadherin; CDH6; α2β1 integrin; RGD motif; Type IV collagen; Metastasis; Therapeutic antibodies;
Antibody therapies in CNS diseases
Keywords: آنتی بادی های درمانی; Blood-brain barrier; Alzheimer's disease; Therapeutic antibodies; Delivery;
Linear models of ovine IgG1 and IgG2 subclasses and predicted pepsin cleavage sites
Keywords: آنتی بادی های درمانی; Immunoglobulin; Therapeutic antibodies; Protease; Sheep; In silico; Neoepitope;
Bioanalysis of bevacizumab and infliximab by high-temperature reversed-phase liquid chromatography with fluorescence detection after immunoaffinity magnetic purification
Keywords: آنتی بادی های درمانی; Therapeutic antibodies; High-temperature reversed-phase liquid chromatography; Immunoaffinity purification; Bevacizumab; Infliximab
TLR3 triggering regulates PD-L1 (CD274) expression in human neuroblastoma cells
Keywords: آنتی بادی های درمانی; Neuroblastoma; Immune therapy; PD-1/PD-L1; Immune checkpoint blockade; TLR ligands in cancer therapy; Therapeutic antibodies
Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases
Keywords: آنتی بادی های درمانی; Therapeutic antibodies; Infectious diseases; IgG subclasses; Antibody-dependent effector mechanisms;
Vers une maîtrise industrielle du clonage des lymphocytes B humains pour la fabrication des anticorps monoclonaux issus du répertoire humain
Keywords: آنتی بادی های درمانی; Anticorps monoclonaux; CD40; Anticorps thérapeutiques; Lymphocytes B humains; Clonage; Monoclonal antibodies; CD40; Therapeutic antibodies; Human B lymphocytes; Cloning;
Three clinical-stage tumor targeting antibodies reveal differential expression of oncofetal fibronectin and tenascin-C isoforms in human lymphoma
Keywords: آنتی بادی های درمانی; Extra domain A of fibronectin; Extra domain B of fibronectin; Extra domain A1 of tenascin-C; Lymphoma; Therapeutic antibodies; Vascular targeting;
Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: Two human antibodies investigated in clinical trials in patients with cancer
Keywords: آنتی بادی های درمانی; Therapeutic antibodies; Extra-domain B of fibronectin; Extra-domain A1 of tenascin-C; Non-small cell lung cancer; Mesothelioma; Tumor-targeting
Targeting the tetraspanin CD81 blocks monocyte transmigration and ameliorates EAE
Keywords: آنتی بادی های درمانی; Tetraspanins; CD81; Multiple sclerosis; Transendothelial migration; Therapeutic antibodies; EAE
FcγR: The key to optimize therapeutic antibodies?
Keywords: آنتی بادی های درمانی; Fc-receptors; Therapeutic antibodies; Optimization of monoclonal antibodies
Structure–function relationships of the variable domains of monoclonal antibodies approved for cancer treatment
Keywords: آنتی بادی های درمانی; Therapeutic antibodies; Variable domain; Paratope; Epitope; Oncology; Cancer; Rituximab; Cetuximab; Alemtuzumab; Trastuzumab; Bevacizumab; Monoclonal antibody; IMGT
Le point sur les anticorps autorisés en imagerie et en immunothérapie
Keywords: آنتی بادی های درمانی; Anticorps thérapeutiques; Imagerie; Immunoscintigraphie; Immunothérapie; Anticorps humanisés; Therapeutic antibodies; Imaging; Immunoscintigraphy; Immunotherapy; Humanized antibodies;
Intraspinal administration of an antibody against CD81 enhances functional recovery and tissue sparing after experimental spinal cord injury
Keywords: آنتی بادی های درمانی; Drug delivery; Tetraspanins; Therapeutic antibodies; Spinal cord injury; Inflammation; Gliosis; Neuroprotection
Tailor-made antibody therapeutics
Keywords: آنتی بادی های درمانی; Therapeutic antibodies; Antibody engineering; Affinity maturation; Effector functions; FcRn binding; Antibody fragments; Immunoconjugates; Immunotoxins; Immunocytokines; ADEPT; Radio-labeled antibodies; Bi-specific antibodies; PEGylation;